Hansen Ree A, Nygaard V, Boye K, Heinrich D, Dueland S, Riise Bergheim I, et al. Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer – the MetAction study. AO [Internet]. 2020 Jul. 2 [cited 2026 Jul. 20];59(7):733-40. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24238